• Vt. to get $1.1 million drug settlement
    November 17,2012
    • Email Article
    •  
    •  Print Article
     
    MONTPELIER — Vermont’s attorney general says the state will receive $1.1 million as part of a national settlement with pharmaceutical manufacturer GlaxoSmithKline over allegations that the company deceptively marketed a diabetes drug.

    The complaint accuses GlaxoSmithKline LLC of engaging in unfair and deceptive practices by misrepresenting Avandia’s cardiovascular risks and safety profile.

    Vermont Attorney General William Sorrell said Thursday that GlaxoSmithKline has reached a $90 million settlement with 37 other attorneys general and has agreed to change how it markets and promotes diabetes drugs.
    • Email Article
    •  
    •  Print Article
    2 Comments
    MORE IN Vermont News
    MONTPELIER — The House Democratic leadership backed away from a vote on legalizing marijuana... Full Story
    MONTPELIER — A bill dealing with independent contractors was resurrected from a quiet death only ... Full Story
    WASHINGTON — Trailing significantly in the Democratic primaries, Bernie Sanders wants... Full Story
    More Articles